Login

Fubo CEO David Gandler discusses the company's 4Q earnings and the competitive landscape of sports streaming with Diane King Hall. 00:10:00

Share On Facebook Share On Twitter

David Gandler is Co-founder and CEO of FuboTV Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Tudor Gold: Advancing Treaty Creek in BC's Golden Triangle with Strong Resource Potential
00:10:00
The Aeons of Gaza: Unveiling Centuries of History and Struggle|Robert Thornett, Professor, Northern Virginia Community College outside Washington, D.C.
00:10:00
Awale Resources: Strategic Advancements and Promising Exploration in Côte d'Ivoire
00:10:00
Biotech Analysts Unveil AI's Impact: Revolutionizing Drug Discovery for a Promising 2024|JEFFREY M. SOLOMON,President, TD Cowen
00:10:00
McKinsey Senior Partners Unveil Groundbreaking Insights: Six Mindsets That Define Exceptional CEOs| Gautam Kumra,Chairman, McKinsey
00:10:00
Breaking Ground: Realto Mining's Journey with the Phoenix Gold Project
00:10:00
A CEO's Insights on Growth, Risk Management, and Urban Development Challenges | Leandro Melnick , CEO,Even Construtora e Incorporadora SA.
00:10:00
BPEA Acquisition Propels EQT Into Buyout Big Leagues | Christian Sinding, CEO, EQT.
00:00:00
4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma
00:10:00
Drax Group CEO Will Gardiner responds to inquiries regarding Drax's Canadian biomass operations in a video statement and provides additional details in the accompanying article.
00:10:00
Lorenzo Volpi on Diversified ILS Strategies and Market Insights at Artemis ILS Asia 2023
00:10:00
Find Peace and Purpose with Tailored Financial Planning at Echo Collaborativ

© 2017 - Neuhu+